Thus, although LPS/LBP-induced immune response is commonly involved in arterial stiffness [41], obesity, and insulin resistance [6, 8–13], our results indicate that the LPS/LBP-induced innate immunity independently affects arterial stiffness in patients with type 2 diabetes. The gene discussed is LBP; the disease is obesity due to melanocortin 4 receptor deficiency.